Latest News about MRK
Recent news which mentions MRK
Is Merck Moving Toward Another Blockbuster Drug Launch?
October 26, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 24, 2022
From Benzinga
7 Stocks to Sell Before They Give Back This Year’s Gain
October 24, 2022
From InvestorPlace
Merck's Antiviral Therapy Shows Efficacy In Prevention of Cytomegalovirus In Kidney Transplant Patients
October 24, 2022
Tickers
MRK
From Benzinga
From InvestorPlace
Beat the Dow Jones With This Unstoppable Dividend Stock
October 19, 2022
From Motley Fool
Merck Outlicenses Two Preclinical TB Candidates To Bill & Melinda Gates Research Institute
October 18, 2022
Tickers
MRK
From Benzinga
Will This News Send Moderna's Stock Soaring?
October 18, 2022
From Motley Fool
Jupiter Wellness's Potential New OTC Drug Could Put Some More Joy Back Into Breast Cancer Survivors' Lives
October 18, 2022
From Benzinga
What the Smartest Investors Know About Moderna Stock
October 18, 2022
From Motley Fool
5 Top Stocks Cathie Wood Is Buying This Week
October 17, 2022
From InvestorPlace
Why Shares of Keros Therapeutics Rose 10.2% This Week
October 14, 2022
From Motley Fool
Health Care Exposure Ahead Of CPI Data, Progressive, Dollar General And Seagate Technology Feature On CNBC's 'Final Trades'
October 13, 2022
From Benzinga
These 2 Stocks Gave Investors a Nice Surprise Wednesday
October 12, 2022
From Motley Fool
Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?
October 12, 2022
From Benzinga
Why Moderna Stock Is Bolting Higher Today
October 12, 2022
From Motley Fool
Why Is Moderna (MRNA) Stock Up 10% Today?
October 12, 2022
From InvestorPlace
Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot
October 12, 2022
From Benzinga
From Benzinga
Why Moderna Stock Is Moving Higher Today
October 12, 2022
From Benzinga
From Motley Fool
With Meaningful Upside, This Cancer Stock Earns Analyst Upgrade
October 11, 2022
From Benzinga
From Benzinga
Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing
October 11, 2022
From Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
October 11, 2022
From Benzinga
What Is Going on With Ginkgo Bioworks (DNA) Stock Today?
October 11, 2022
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.